Management of dyslipidaemias.
Management of dyslipidaemias.
复制标题
血脂异常的管理。
DOI:
10.1136/hrt.2005.071712
复制
发表时间:
2006
期刊:
影响因子:
--
通讯作者:
Knopp,Robert
中科院分区:
文献类型:
--
作者:
Paramsothy,Pathmaja;Knopp,Robert
Atherosclerotic disease is the leading cause of death among men and women in Europe, the United States, and worldwide. 1 2 Previously considered a ‘‘western’’disease, it is now clear that various peoples of diverse ethnic backgrounds are vulnerable to atherosclerosis. The epidemic of obesity, especially abdominal obesity, escalates the need for appropriate detection and management of high risk individuals. The overwhelming consumption of economic and medical resources necessitates preventive measures in order to decrease the global burden of heart disease. The recent Interheart study, a very large case–control study of acute myocardial infarction in 52 countries, demonstrates that traditional risk factors for coronary heart disease (CHD) account for most of the risk worldwide (over 90%) and include abnormal lipids, smoking, diabetes, hypertension, abdominal obesity, psychosocial factors, diminished consumption of fruits and vegetables, lack of regular alcohol intake, and lack of regular physical activity. The two most potent risk factors worldwide are smoking and dyslipidaemia. 3 The forefront of primary and secondary prevention of CHD is the management of dyslipidaemia. This article will review current strategies in managing dyslipidaemias, focusing on drug treatment and the adjunctive role of diet.